Article No
173-24200
Glucagon-like Protein Receptor (GLP2R) Antibody
Glucagon-like Protein Receptor (GLP2R) Antibody
Antibodies Primary
Specifications
| MW | The antiserum demonstrates significant labeling of enteroendocrine cells in the intestinal epithelium, as well as cell bodies of vagal afferents in nodose ganglia of the parasympathetic nervous system. Immunolabeling of Western blot revealed a band of approximately 66 kDa in human and rat tissue. |
| Application | IHC |
| Article No | 173-24200 |
| Country Availability | SE, FI, DK, NO, IS, EE, LV, LT, FO, GL |
| Clone Type | polyclonal |
| Conjugation | Unconjugated |
| Description | Glucagon-like Protein Receptor (GLP2R) Antibody |
| Supplier | ImmunoStar |
| Format | Affinity Purified |
| Immunogen | Glucagon-like peptide 2 receptor (GLP2R) for acetyl 65-88 amide sequence targeting rat and human proteins, but not mouse. |
| Notes | The rabbit antibody for Glucagon-like Protein Receptor is generated for acetyl 65-88 amide sequence targeting rat and human proteins, but not mouse. The peptide was synthesized and cross-linked to keyhole limpet hemocyanin via sulfolink coupling. |
| Previous Article No | 173-24200, 24200 |
| Product Type | Antibodies Primary |
| Research area | Neuroscience, Cell Signaling |
| Size | 100 µl |
| Source / Host | rabbit |
| Species Reactivity | rat |
| Substrate / Buffer | The rabbit antibody for Glucagon-like Protein Receptor is generated for acetyl 65-88 amide sequence targeting rat and human proteins, but not mouse. The peptide was synthesized and cross-linked to keyhole limpet hemocyanin via sulfolink coupling. The antibody is provided as 100 µL of affinity purified serum containing 1% BSA. |
| Technical Specifications | This product contains the preservative sodium azide. The concentration percent of the sodium azide is ≤ .09%. Although this hazardous substance is a concentration below that required for the preparation of a Material Safety Data Sheet, we created a standard MSDS for your records. |
| Product Page Updated | 2024-01-03T12:30:51.564Z |
